Skip to content
value.today

AtheroMed Inc

Total raised
$25 M
5 rounds on record
Latest round
$4 M
Dec 2013
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of AtheroMed Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2013$4 MNo. 5$2 to $10 million

AtheroMed Inc: Raise no. 5, Dec 2013

Investors in this round

25 investors had bought by the notice of Dec 10, 2013: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael MacKinnon · Executive Officer, Director
  • Alan Kaganov · Director
  • Casey Tansey · Director
  • David Schulte · Director
  • Tony Chou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael MacKinnon, President and CEO. Source: SEC Form D, newest notice filed Dec 10, 2013. Read the notice at the SEC.

debt, optionsSEC
Mar 2013$6 MNo. 4$2 to $10 million

AtheroMed Inc: Raise no. 4, Mar 2013

Investors in this round

19 investors had bought by the notice of Apr 3, 2013: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Danek · Executive Officer
  • Mike MacKinnon · Executive Officer
  • Alan Kaganov · Director
  • Casey Tansey · Director
  • David Schulte · Director
  • Tony Chou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mike MacKinnon, President. Source: SEC Form D, newest notice filed Apr 3, 2013. Read the notice at the SEC.

equitySEC
Mar 2012$4 MNo. 3$2 to $10 million

AtheroMed Inc: Raise no. 3, Mar 2012

Investors in this round

21 investors had bought by the notice of Mar 21, 2012: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Danek · Executive Officer
  • Will McGuire · Executive Officer, Director
  • Alan Kaganov · Director
  • Casey Tansey · Director
  • David Schulte · Director
  • Tony Chou · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The actual total offering amount:$4,479,484.56; The actual total amount sold: $4,479,482.64”

Signed by Will McGuire, Ceo. Source: SEC Form D, newest notice filed Mar 21, 2012. Read the notice at the SEC.

equity, optionsSEC
Mar 2011$8 MNo. 2$2 to $10 million

AtheroMed Inc: Raise no. 2, Mar 2011

Investors in this round

17 investors had bought by the notice of May 6, 2011: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Danek · Executive Officer
  • Will McGuire · Executive Officer, Director
  • Alan Kaganov · Director
  • Casey Tansey · Director
  • David Schulte · Director
  • Ken Ludlum · Director
  • Tony Chou · Director
  • John To · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Danek, Secretary. Source: SEC Form D, newest notice filed May 6, 2011. Read the notice at the SEC.

equitySEC
Oct 2009$2 MNo. 1$2 to $10 million

AtheroMed Inc: Raise no. 1, Oct 2009

Investors in this round

18 investors had bought by the notice of Dec 11, 2009: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $11 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Danek · Executive Officer, Director, Promoter
  • Alan Kaganov · Director
  • Casper De Clercq · Director
  • David Schulte · Director
  • Ken Ludlum · Director
  • Tony Chou · Director
  • John To · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Danek, President. Source: SEC Form D, newest notice filed Dec 11, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • AtheroMed Inc chose not to state its revenue in its newest notice of a funding round (Dec 2013).

    SEC Form D · Dec 2013

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2013

That is all the official record says: AtheroMed Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of AtheroMed Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 25 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by AtheroMed Inc
NameRoleNamed in
Michael MacKinnonExecutive officerDec 2013
Chris DanekExecutive officerApr 2013
Mike MacKinnonExecutive officerApr 2013
Will McGuireExecutive officerMar 2012
Alan KaganovDirectorDec 2013
Casey TanseyDirectorDec 2013
David SchulteDirectorDec 2013
Michael MacKinnonDirectorDec 2013
Tony ChouDirectorDec 2013
Will McGuireDirectorMar 2012
Ken LudlumDirectorMay 2011
Casper De ClercqDirectorDec 2009
Chris DanekDirectorDec 2009
John ToPromoterMay 2011
Chris DanekPromoterDec 2009